Upside – $MEDS +36% (preliminary September pharmacy revenue exceeded $1M, rising more than 66% from July) – $ACN +17% (Q4 beat with $22.2B of bookings and stronger operating margins) – $ABAT +13% (receives federal approval to export up to $100M of recycled black-mass material) – $QSI +13% (no clear fresh catalyst identified; unusually large move …
Read in context ›Vicor Stock (VICR)
Track Vicor stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
VICR
Vicor
technology
At close
$266.07
▲ +3.75 (+1.43%)
Oct 9, 4:00 PM ET
After-hours
$271.00
▲ +4.93 (+1.85%)
Oct 9, 7:59 PM ET
Market Cap
$12.09B
P/E Ratio
84.0x
1Y Return
+405.64%
EPS (TTM)
$3.12
Read the latest TheStreet Pro articles mentioning Vicor, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
1 articleDaily Diary Mentions
3 mentionsUpside, Downside Movers in the Morning Upside, Downside Movers Upside – $GRML +44% (extends the high-volume Greenland critical-minerals momentum rally) – $VKTX +25% (positive VK2735 maintenance data showed strong weight loss and high retention with biweekly and monthly dosing) – $VICR +8.7% (raises Q3 sequential revenue-growth guidance to more than 20% from nearly 10% on V4PD-license royalties) – $ONON +8.0% (sets high-teens constant-currency sales …
Read in context ›Upside, Downside Movers in the Morning Upside – $AEMD +403% (merger agreement with North Immunology adds an IL-13 x IL-18 bispecific-antibody program for atopic dermatitis) – $GNRC +30% (Amazon supply agreement includes $2.4B of backup-generator deliveries expected during 2027-2028) – $VEEA +30% (non-binding combination term sheet with NovaGen targets a $750M AI-health platform) – $DTSS +12% (strategic cooperation expands into AI-powered …
Read in context ›